Sorted By:


Protecting Patients From Dangerous Counterfeit Drugs

PhRMA  |  Blog Post

John also commended the Administration for its increased attention to the worldwide counterfeit medicine threat.

Focusing Payment and Delivery on Patients

PhRMA  |  Blog Post

(More on HHS’ initiative here and here.)

Pfizer’s Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts

PhRMA  |  Press Release

“Our trade association will continue to play a constructive role in the pursuit of policies that will help ensure access to our medicines and create an environment that will help generate future medical innovation for the benefit of patients in the United States and around the world.”

Patient Profile: Out-of-Pocket Cost Burden for Patients Treating Mental Health Conditions

PhRMA  |  Blog Post

Past research shows, those with lower-income family budgets are most likely to use their income for necessities such as food, housing, taxes and transportation.

I'm Not Average: 13 Years Later, Jamie Is Still Here

PhRMA  |  Blog Post

Jamie’s story is part of PhRMA’s new campaign, I’m Not Average, to share inspirational stories from individuals about the powerful impact advances and innovations in cancer medicines have had on their lives.

Week in Review: Keeping Patients In-The-Know

PhRMA  |  Blog Post

We will continue to post resources and helpful information to our website and on social media in honor of Rare Disease Week and Rare Disease Day, and will be highlighting the various tweetchats that occurred in our latest Conversations forum later this week.

Kenneth Thorpe, Ph.D.

PhRMA  |  Biography

Thorpe is a frequent commenter on health care issues in the print media and television.

Illustrative Pharmaceutical Lifecycle

Chartpack  |  From Our Network

Savings free up program resources for the next generation of medical advances from innovators.

Mental Health Medicines in Development Report, 2014

PhRMA  |  Report

Trying to Fool Cancer

From Hope To Cures  |  From Our Network

CLEVELAND — WHEN it airs on Monday, the Ken Burns-produced documentary “Cancer: The Emperor of All Maladies” will emphasize how much more we now know about the genetic basis for ." href="

PhRMA Member Companies Invested $49.5 Billion In Research and Development in 2011

PhRMA  |  Press Release

Find PhRMA Online: Website – facebook – Blog – Twitter – and YouTube – For information on how innovative medicines save lives, visit: For information on the Partnership for Prescription Assistance, visit: For information on ensuring the flow of medicines during public health emergencies, visit

Castellani Statement on Prescription Drug Costs

PhRMA  |  Press Release

This is a far larger increase in out-of-pocket costs than was found for other medical care.

Prioritizing Patients: A Discussion on Outcomes-Based Care

PhRMA  |  Video

Speakers: Senator Bill Cassidy (R-LA), Member, Senate Committee on Health, Education, Labor & Pensions Congresswoman Doris Matsui (D-CA), Member, House Energy and Commerce Committee Liz Fowler, Vice President, Global Health Policy, Johnson & Johnson Patrick Geraghty, CEO, GuideWell and Florida Blue Marilyn Serafini, Health Care Policy Consultant Pamela Sutton-Wallace, CEO, University of Virginia Medical Center Stephen J.

PhRMA Statement on Prescription Drug Importation

PhRMA  |  Press Release

In fact, an FDA investigation found that mail packages containing prescription drugs from ‘Canada’ came from 27 countries globally – such countries include India, Costa Rica and Vanuatu.

New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS

PhRMA  |  Press Release

Despite this progress, AIDS remains a devastating and growing health problem in developing countries, particularly in sub-Saharan Africa, China, India and the Russian Federation.

Medicare Monday: What is CMMI?

PhRMA  |  Blog Post

Earlier this year, Medicare set a goal of moving 50 percent of payments into APMs by 2018.

How You Can Help Fight a $1.1 Trillion Disease

PhRMA  |  Press Release

For more information about how you can help support caregivers, patients and medical innovation, please go to

The Biopharmaceutical Pipeline

PhRMA  |  Report

Key findings:  74 percent of medicines in clinical development are potentially first-in-class medicines, meaning they represent a possible new pharmacological class for treating a medical condition.

New Study: Policy Environment Has a Significant Impact on Biopharmaceutical Investment

PhRMA  |  Blog Post

Meir Perez Pugatch is an IPKM Professor of Innovation, Entrepreneurship and Management at the University of Maastricht in the Netherlands.

The ABCs of Health Coverage

PhRMA  |  Blog Post

We’ve already released two videos to help cut through the clutter about basic insurance terms and how insurance covers your medicines.

PhRMA Statement on Sustainability & Manufacturing Process

PhRMA  |  Press Release

(April 23, 2009) — Pharmaceutical Research and Manufacturers of America Senior Vice President Ken Johnson issued the following statement today in response to recent media attention surrounding pharmaceutical ingredients discharged by manufacturing facilities: “Recent public concern about media reports of traces of medicines in the water deserves some clarification of the role America’s pharmaceutical companies play in fostering sustainable manufacturing practices as part of their goal of delivering new medicines to patients.

Joint Industry Statement: Internet Sales and Access to Safe Medicines

PhRMA  |  Press Release

Customs and Border Protection, Newsroom, 2012 European Commission, Headlines, 2011 Interpol, News and Media, 2011 PSI, 2012 PSI, News and Media, 2012

Biopharmaceutical Research Companies Developing 92 Medicines to Treat Arthritis and Musculoskeletal Diseases

PhRMA  |  Blog Post

  These medicines, according to a new Medicines in Development report by PhRMA, are either in clinical trials or awaiting review by the U.S.

Manager – Public Affairs

PhRMA  |  PhRMA Career

We offer traditional (medical, dental, vision, flexible spending, life, AD&D, LTD, STD, LTC) and enhanced benefits such as parental leave, health advocate service, back-up childcare, commuting and financial & estate planning benefits.

New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need

PhRMA  |  Blog Post

In the I-ACT launch announcement, Johnson & Johnson’s Chief Medical Officer Joanne Waldstreicher, MD noted, "dedicated, science-driven expertise is critical to developing safe, effective and properly formulated therapies for children.

You have reviewed the first 375 results out of 1047. Each page contains 25 results. You're on page 15.

prev 13 14 15 16 17 18 next